Cooper Companies | COO - Creditori Commerciali

Prezzo Delle Azioni
63.09
Cambio Giornaliero
-1.25 -1.94%
Mensile
-8.97%
Annuale
-23.28%
Q2 Previsione
63.04




Creditori Commerciali Cambiamento Data
Abbott USD 4.24B 117M 2025-12
Align Technology USD 121.45M 4.1M 2025-12
AtriCure USD 78.4M 3.56M 2025-12
Avanos Medical USD 55.5M 1.3M 2025-12
Bausch Health Companies USD 600M 16M 2025-12
Baxter International USD 999M 46M 2025-12
Bayer EUR 7.08B 700M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Dentsply International USD 300M 32M 2025-12
Dexcom USD 1.83B 1.38B 2025-12
Edwards Lifesciences USD 227.5M 62.5M 2025-12
Globus Medical USD 98.85M 11.62M 2025-12
Haemonetics USD 48.69M 13M 2025-12
Inogen USD 21.22M 684K 2025-09
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intuitive Surgical USD 1.85B 68.6M 2026-03
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 60.55M 4.19M 2025-12
Novartis USD 4.46B 99M 2025-12
ResMed USD 250.41M 16.37M 2025-12
STAAR Surgical USD 11.57M 2.39M 2025-12
Steris USD 285.1M 23.8M 2025-12
Stryker USD 1.5B 56M 2025-09
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teleflex USD 130.2M 35.71M 2025-12
Utah Medical Products USD 911K 143K 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12